DV
Dividend Vision

ACTU — Actuate Therapeutics, Inc. Common stock

Actuate Therapeutics, Inc. Common stock (ACTU)

Total return is -88.3% over the past 2 years, 134.9 points behind SPY at 46.6%. Its deepest 1-year drawdown was 88.9%.

This appears to be individual company stock rather than an ETF product. Actuate Therapeutics is a single equity security with no stated dividend distribution rate or expense ratio typical of ETFs. The product lacks standard ETF characteristics including a formal objective statement, fund type classification, asset management details, and distribution frequency, making it unsuitable for dividend income strategies that ETF investors typically employ.

ACTU key facts

Asset type
Stock
Asset class
Equity
Inception date
08/13/2024
Last close
$1.01
Market cap
$34,453,228
Average volume
109727.0
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.98